AAAAAA
Results:
1-8
|
Results: 8
Authors:
Weiss, MG
Isaac, M
Parkar, SR
Chowdhury, AN
Raguram, R
Citation: Mg. Weiss et al., Global, national, and local approaches to mental health: examples from India, TR MED I H, 6(1), 2001, pp. 4-23
Authors:
Slassi, A
Isaac, M
Arora, J
Citation: A. Slassi et al., Novel serotonergic and non-serotonergic migraine headache therapies, EXPERT OP T, 11(4), 2001, pp. 625-649
Authors:
Isaac, M
Slassi, A
Da Silva, K
Arora, J
MacLean, N
Hung, B
McCallum, K
Citation: M. Isaac et al., 5,5-diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors, BIOORG MED, 11(11), 2001, pp. 1371-1373
Authors:
Isaac, M
Citation: M. Isaac, The 5-HT2C receptor as a potential therapeutic target for the design of antiobesity and antiepileptic drugs, DRUG FUTURE, 26(4), 2001, pp. 383-393
Authors:
Isaac, M
Slassi, A
Da Silva, K
Xin, T
Citation: M. Isaac et al., Synthesis of chiral and geometrically defined 5,5-diaryl-2-amino-4-pentenoates: navel amino acid derivatives, TETRAHEDR L, 42(16), 2001, pp. 2957-2960
Authors:
Isaac, M
Slassi, A
O'Brien, A
Edwards, L
MacLean, N
Bueschkens, D
Lee, DKH
McCallum, K
De Lannoy, I
Demchyshyn, L
Kamboj, R
Citation: M. Isaac et al., Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: Potential therapeutic applications for epilepsy and obesity, BIOORG MED, 10(9), 2000, pp. 919-921
Authors:
Isaac, M
Slassi, A
Xin, T
MacLean, N
Wilson, J
McCallum, K
Wang, H
Demchyshyn, L
Citation: M. Isaac et al., 6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists, BIOORG MED, 10(15), 2000, pp. 1719-1721
Authors:
Isaac, M
Citation: M. Isaac, Where are we going with SSRIs?, EUR NEUROPS, 9, 1999, pp. S101-S106
Risultati:
1-8
|